Sidley Austin LLP advised Pyxis Oncology, Inc. on the transaction, while Wilson Sonsini advised Apexigen on the transaction. Pyxis Oncology, Inc., a clinical-stage company, and Apexigen,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Enliven Therapeutics on the deal. Enliven Therapeutics, a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Kedalion Therapeutics on the deal. Novartis announced that it acquired Kedalion Therapeutics and its AcuStream technology, an innovative device that may have the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised GeoPhy on the deal while Arnold & Porter advised Walker & Dunlop. Walker & Dunlop announced it has entered into...
You must be a Standard 1 Year member to access this content.
Dechert advised Antios Therapeutics on the deal. Antios Therapeutics, Inc. (“Antios”) completed its $96 million Series B financing. Antios is a clinical-stage biopharmaceutical company focused on the...
You must be a Standard 1 Year member to access this content.
Dechert and Miller Thomson advised B&G Foods on the deal. B&G Foods, Inc. signed the agreement to acquire the Crisco® brand of oils and shortening from...
You must be a Standard 1 Year member to access this content.
